The effects of chemotherapy and radiotherapy on fertility in premenopausal women

Obstet Gynecol Surv. 2011 Apr;66(4):248-54. doi: 10.1097/OGX.0b013e318224e97b.

Abstract

With the improved survival rate of childhood and young adult cancer patients, the long-term sequelae of the treatments used are increasingly important. In this review, current knowledge of the gonadotoxicity of commonly employed chemotherapeutic agents and radiotherapy regimens is examined. Differences between the effect of "high-risk" and "low-risk" agents are discussed. Tailoring treatment to suit the individual and counseling patients regarding reduced fertility have resulted in the best practice.

Target audience: Obstetricians & Gynecologists, Family Physicians.

Learning objectives: After completing this CME activity, physicians should be better able to evaluate and use appropriate methods to estimate ovarian reserve, assess the risk of infertility caused by commonly used cytotoxic chemotherapy regimens and radiation, and counsel patients regarding the gonadotoxic effects of cancer treatment.

Publication types

  • Review

MeSH terms

  • Amenorrhea / chemically induced
  • Antineoplastic Agents / adverse effects*
  • Female
  • Fertility / drug effects*
  • Fertility / radiation effects*
  • Humans
  • Menopause, Premature / drug effects
  • Neoplasms / drug therapy*
  • Neoplasms / radiotherapy*
  • Ovary / drug effects
  • Ovary / radiation effects
  • Primary Ovarian Insufficiency / chemically induced
  • Radiotherapy / adverse effects

Substances

  • Antineoplastic Agents